Evidence mapPaperPMID 27464676Full record

GuidelinePediatrics2016

Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders.

H Eugene Hoyme, Wendy O Kalberg, Amy J Elliott, Jason Blankenship, David Buckley, Anna-Susan Marais, Melanie A Manning, Luther K Robinson, Margaret P Adam, Omar Abdul-Rahman and 10 more

Registry-linked trialOpen access · bronzeAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07456579 (Assessment of Alcohol and Cannabis Use Among Pregnant Women in Slovenia and Meconium Microbiome Analysis of Positive Samples), which is not on this map. Cited by 409 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
409citing papers in PubMed, 2 pooled it
124.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07456579 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Assessment of Alcohol and Cannabis Use Among Pregnant Women in Slovenia and Meconium Microbiome Analysis of Positive Samples

TypeobservationalSponsorUniversity Medical Centre LjubljanaRan2024 to 2026Enrolled600ConditionsMicrobiome Analysis, Drug Abuse in Pregnancy, Alcohol Abuse in Pregnancy, Health Behavior, Risky
3 · Its place in the literature

Who cites it

409 citing papers in PubMed, 2 syntheses or guidelines pooled it, 855 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Increasing Access to FASD-Informed Care: Bringing an Adapted Intervention to Mental Health Providers.Evidence-based practice in child and adolescent mental health · 2026
    Article
  12. Alcohol Metabolism into Acetaldehyde in Developing Cerebral Arteries.International journal of molecular sciences · 2026
    Article
  13. Article
  14. Prenatal Alcohol Exposure and Dysmorphic Features in Adults at Midlife.Alcohol, clinical & experimental research · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

349 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 2 countries.

H Eugene HoymeSanford Research and Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota; Center for Applied Genetics and Genomic Medicine and Department of Pediatrics, University of Arizona College of Medicine, Tucson, Arizona; gene.hoyme@sanfordhealth.org.
Wendy O KalbergCenter on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque, New Mexico;
Amy J ElliottSanford Research and Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota;
Jason BlankenshipCenter on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque, New Mexico;
David BuckleyCenter on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque, New Mexico;
Anna-Susan MaraisStellenbosch University Faculty of Medicine and Health Sciences, Stellenbosch, South Africa;
Melanie A ManningDepartments of Pathology and Pediatrics, Stanford University School of Medicine, Stanford, California;
Luther K RobinsonDepartment of Pediatrics, State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York;
Margaret P AdamDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington;
Omar Abdul-RahmanDepartment of Pediatrics, University of Mississippi School of Medicine, Jackson, Mississippi;
Tamison JewettDepartment of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina;
Claire D ColesDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia;
Christina ChambersDepartment of Pediatrics, University of California, San Diego School of Medicine, La Jolla, California;
Kenneth L JonesDepartment of Pediatrics, University of California, San Diego School of Medicine, La Jolla, California;
Colleen M AdnamsDepartment of Psychiatry and Mental Health, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa;
Prachi E ShahDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan;
Edward P RileyDepartment of Psychology, San Diego State University, San Diego, California;
Michael E CharnessVA Boston Healthcare System, Department of Neurology, Harvard Medical School, and Department of Neurology, Boston University School of Medicine, Boston, Massachusetts;
Kenneth R WarrenNational Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland; and.
Philip A MaySanford Research and Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota; Center on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque, New Mexico; Department of Nutrition, Gillings School of Global Public Health, Nutrition Research Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
University of New Mexico · USUniversity of California, San Diego · USEmory University · USNational Institute on Alcohol Abuse and Alcoholism · USSan Diego State University · USSanford Research · USStanford University · USStellenbosch University · ZAUniversity at Buffalo, State University of New York · USUniversity of Arizona · USUniversity of Cape Town · ZAUniversity of Michigan–Ann Arbor · USUniversity of Mississippi · USUniversity of South Dakota · USUniversity of Washington · USVA Boston Healthcare System · USWake Forest University · US

Funding

Collaboration to Establish the Prevalence of FASD in San Diego, CAU01AA019879 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHAMBERS, CHRISTINA · 2010 to 2017
$9.2M
Trajectory of Fetal Alcohol Spectrum Disorders (FASD) Across the Lifespan: Continuing Prevention and Longitudinal EpidemiologyU01AA015134 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAY, PHILIP ALAN · 2009 to 2018
$7.8M
TRIAL OF FAS PREVENTION IN AMERICAN INDIAN COMMUNITIESR01AA011685 · NIAAA · UNIVERSITY OF NEW MEXICO · PI MAY, PHILIP ALAN · 1998 to 2001
$3.1M
Alcohol AntagonistsI01BX002374 · VA · VA BOSTON HEALTH CARE SYSTEM · PI CHARNESS, MICHAEL EDWARD · 2015 to 2019
NIAAA NIH HHS R01 AA011685NIAAA NIH HHS U01 AA019879
6 · The paper itself

Abstract

The adverse effects of prenatal alcohol exposure constitute a continuum of disabilities (fetal alcohol spectrum disorders [FASD]). In 1996, the Institute of Medicine established diagnostic categories delineating the spectrum but not specifying clinical criteria by which diagnoses could be assigned. In 2005, the authors published practical guidelines operationalizing the Institute of Medicine categories, allowing for standardization of FASD diagnoses in clinical settings. The purpose of the current report is to present updated diagnostic guidelines based on a thorough review of the literature and the authors' combined expertise based on the evaluation of >10 000 children for potential FASD in clinical settings and in epidemiologic studies in conjunction with National Institute on Alcohol Abuse and Alcoholism-funded studies, the Collaborative Initiative on Fetal Alcohol Spectrum Disorders, and the Collaboration on FASD Prevalence. The guidelines were formulated through conference calls and meetings held at National Institute on Alcohol Abuse and Alcoholism offices in Rockville, MD. Specific areas addressed include the following: precise definition of documented prenatal alcohol exposure; neurobehavioral criteria for diagnosis of fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder; revised diagnostic criteria for alcohol-related birth defects; an updated comprehensive research dysmorphology scoring system; and a new lip/philtrum guide for the white population, incorporating a 45-degree view. The guidelines reflect consensus among a large and experienced cadre of FASD investigators in the fields of dysmorphology, epidemiology, neurology, psychology, developmental/behavioral pediatrics, and educational diagnostics. Their improved clarity and specificity will guide clinicians in accurate diagnosis of infants and children prenatally exposed to alcohol.

Indexed as

AdolescentAlcohol DrinkingChildChild, PreschoolDiagnosis, DifferentialFetal Alcohol Spectrum DisordersHumansInfantInfant, NewbornMaternal BehaviorNeuropsychological TestsPediatricsPhysical ExaminationPhysician's RoleSensitivity and Specificity

Identifiers

PMID27464676
PMCPMC4960726
OpenAlexW2492998196

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.